Neutralizing and protective antibodies directed against vaccinia virus envelope antigens

Virology

Volumn 254, Issue 1, 1999, Pages 71-80

  Galmiche, Marie C ^a   Goenaga, Jacqueline ^a   Wittek, Riccardo ^a   Rindisbacher, Lorenz ^a,b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLYCOPROTEIN; HEMAGGLUTININ; HYPERIMMUNE GLOBULIN; NEUTRALIZING ANTIBODY; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; BINDING AFFINITY; CELL MEMBRANE; CYTOPLASM; GENE EXPRESSION; GENE REPRESSION; GENOME; IMMUNE RESPONSE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TISSUE CULTURE; VACCINATION; VACCINIA VIRUS; VIRUS ENVELOPE; VIRUS INFECTION;

EID: 0033080182     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9516     Document Type: Article

References (53)

1. Appleyard, G., Hapel, A. J., and Boulter, E. A. (1971). An antigenic difference between intracellular and extracellular rabbitpox virus. J. Gen. Virol. 13, 9-17.
2. Blasco, R., and Moss, B. (1991). Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-dalton outer envelope protein. J. Virol. 65, 5910-5920.
3. Blasco, R., and Moss, B. (1992). Role of cell-associated enveloped vaccinia virus in cell-to-cell spread [published erratum appears in J. Virol. (1992). 66, 5703-5704]. J. Virol. 66, 4170-4179.
4. Boulter, E. A. (1969). Protection against poxviruses. Proc. R. Soc. Med. 62, 295-297.
5. Boulter, E. A., and Appleyard, G. (1973). Differences between extracellular and intracellular forms of poxvirus and their implications. Prog. Med. Virol. 16, 86-108.
6. Boulter, E. A., Zwartouw, H. T., Titmuss, D. H., and Maber, H. B. (1971). The nature of the immune state produced by inactivated vaccinia virus in rabbits. Am. J. Epidemiol. 94, 612-620.
7. Cudmore, S., Cossart, P., Griffiths, G., and Way, M. (1995). Actin-based motility of vaccinia virus. Nature 378, 636-638.
8. Czerny, C. P., and Mahnel, H. (1990). Structural and functional analysis of orthopoxvirus epitopes with neutralizing monoclonal antibodies. J. Gen. Virol. 71, 2341-2352.
9. Duncan, S. A., and Smith, G. L. (1992). Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress. J. Virol. 66, 1610-1621.
10. Eiffert, H., Quentin, E., Wiederhold, M., Hillemeir, S., Decker, J., Weber, M., and Hilschmann, N. (1991). Determination of the molecular structure of the human free secretory component. Biol. Chem. Hoppe-Seyler 372, 119-128.
11. Engelstad, M., Howard, S. T., and Smith, G. L. (1992). A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope. Virology 188, 801-810.
12. Engelstad, M., and Smith, G. L. (1993). The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence. Virology 194, 627-637.
13. Galmiche, M. C., Rindisbacher, L., Wels, W., Wittek, R., and Buchegger, F. (1997). Expression of a functional single chain antibody on the surface of extracellular enveloped vaccinia virus as a step towards selective tumour cell targeting. J. Gen. Virol. 78, 3019-3027.
14. Goebel, S. J., Johnson, G. P., Perkus, M. E., Davis, S. W., Winslow, J. P., and Paoletti, E. (1990). The complete DNA sequence of vaccinia virus. Virology 179, 247-266, 517-563.
15. Hassett, D. E., and Whitton, J. L. (1996). DNA immunization. Trends Microbiol. 4, 307-312.
16. Herrera, E., del Mar Lorenzo, M., Blasco, R., and Isaacs, S. N. (1998). Functional analysis of vaccinia virus B5R protein: Essential role in virus envelopment is independent of a large portion of the extracellular domain. J. Virol. 72, 294-302.
17. Hiller, G., Jungwirth, C., and Weber, K. (1981). Fluorescence microscopical analysis of the life cycle of vaccinia virus in chick embryo fibroblasts: Virus-cytoskeleton interactions. Exp. Cell Res. 132, 81-87.
18. Hiller, G., and Weber, K. (1985). Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment. J. Virol. 55, 651-659.
19. Hirt, P., Hiller, G., and Wittek, R. (1986). Localization and fine structure of a vaccinia virus gene encoding an envelope antigen. J. Virol. 58, 757-764.
20. Ichihashi, Y. (1996). Extracellular enveloped vaccinia virus escapes neutralization. Virology 217, 478-485.
21. Ichihashi, Y., and Dales, S. (1971). Biogenesis of poxviruses: Interrelationship between hemagglutinin production and polykaryocytosis. Virology 46, 533-543.
22. Ichihashi, Y., Matsumoto, S., and Dales, S. (1971). Biogenesis of poxviruses: Role of A-type inclusions and host cell membranes in virus dissemination. Virology 46, 507-532.
23. Isaacs, S. N., Wolffe, E. J., Payne, L. G., and Moss, B. (1992). Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope. J. Virol. 66, 7217-7224.
24. Krajci, P., Grzeschik, K. H., Geurts van Kessel, A. H., Olaisen, B., and Brandtzaeg, P. (1991). The human transmembrane secretory component (poly-lg receptor): Molecular cloning, restriction fragment length polymorphism and chromosomal sublocalization. Hum. Genet. 87, 642-648.
25. Mathew, E., Sanderson, C. M., Hollinshead, M., and Smith, G. L. (1998). The extracellular domain of vaccinia virus protein B5R affects plaque phenotype, extracellular enveloped virus release, and intracellular actin tail formation. J. Virol. 72, 2429-2438.
26. McIntosh, A. A., and Smith, G. L. (1996). Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus. J. Virol. 70, 272-281.
27. Morgan, C. (1976). Vaccinia virus reexamined: Development and release. Virology 73, 43-58.
28. Parkinson, J. E., and Smith, G. L. (1994). Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus. Virology 204, 376-390.
29. Payne, L. G. (1979). Identification of the vaccinia hemagglutinin polypeptide from a cell system yielding large amounts of extracellular enveloped virus. J. Virol. 31, 147-155.
30. Payne, L. G. (1980). Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia. J. Gen. Virol. 50, 89-100.
31. Payne, L. G., and Kristensson, K. (1985). Extracellular release of enveloped vaccinia virus from mouse nasal epithelial cells in vivo. J. Gen. Virol. 66, 643-646.
32. Payne, L. G., and Norrby, E. (1976). Presence of haemagglutinin in the envelope of extracellular vaccinia virus particles. J. Gen. Virol. 32, 63-72.
33. Rindisbacher, L., Cottet, S., Wittek, R., Kraehenbuhl, J. P., and Corthesy, B. (1995). Production of human secretory component with dimeric IgA binding capacity using viral expression systems. J. Biol. Chem. 270, 14220-14228.
34. Roper, R. L., Payne, L. G., and Moss, B. (1996). Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene. J. Virol. 70, 3753-3762.
35. Roper, R. L., Wolffe, E. J., Weisberg, A., and Moss, B. (1998). The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus. J. Virol. 72, 4192-4204.
36. Schmelz, M., Sodeik, B., Ericsson, M., Wolffe, E. J., Shida, H., Hiller, G., and Griffiths, G. (1994). Assembly of vaccinia virus: The second wrapping cisterna is derived from the trans Golgi network. J. Virol. 68, 130-147.
37. Schmutz, C., Rindisbacher, L., Galmiche, M. C., and Wittek, R. (1995). Biochemical analysis of the major vaccinia virus envelope antigen. Virology 213, 19-27.
38. Seki, M., Oie, M., Ichihashi, Y., and Shida, H. (1990). Hemadsorption and fusion inhibition activities of hemagglutinin analyzed by vaccinia virus mutants. Virology 175, 372-384.
39. Shida, H. (1986). Nucleotide sequence of the vaccinia virus hemagglutinin gene. Virology 150, 451-462.
40. Shida, H., and Dales, S. (1982). Biogenesis of vaccinia: Molecular basis for the hemagglutination-negative phenotype of the IHD-W strain. Virology 117, 219-237.
41. Smith, G. L., Sang Chan, Y., and Howard, S. T. (1991). Nucleotide sequence of 42 kbp of vaccinia virus strain WR from near the right inverted terminal repeat. J. Gen. Virol. 72, 1349-1376.
42. Smith, G. L. (1993). Vaccinia virus glycoproteins and immune evasion: The sixteenth Fleming lecture. J. Gen. Virol. 74, 1725-1740.
43. Sodeik, B., Doms, R. W., Ericsson, M., Hiller, G., Machamer, C. E., van't Hof, W., van Meer, G., Moss, B., and Griffiths, G. (1993). Assembly of vaccinia virus: Role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks. J. Cell Biol. 121, 521-541.
44. Stokes, G. V. (1976). High-voltage electron microscope study of the release of vaccinia virus from whole cells. J. Virol. 18, 636-643.
45. Takahashi-Nishimaki, F., Funahashi, S., Miki, K., Hashizume, S., and Sugimoto, M. (1991). Regulation of plaque size and host range by a vaccinia virus gene related to complement system proteins. Virology 181, 158-164.
46. Tooze, J., Hollinshead, M., Reis, B., Radsak, K., and Kern, H. (1993). Progeny vaccinia and human cytomegalovirus particles utilize early endosomal cisternae for their envelopes. Eur. J. Cell Biol. 60, 163-178.
47. Turner, G. S., and Squires, E. J. (1971). Inactivated smallpox vaccine: Immunogenicity of inactivated intracellular and extracellular vaccinia virus. J. Gen. Virol. 13, 19-25.
48. Vanderplasschen, A., Hollinshead, M., and Smith, G. L. (1997). Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation. J. Gen. Virol. 78, 2041-2048.
49. Vanderplasschen, A., Hollinshead, M., and Smith, G. L. (1998). Intracellular and extracellular vaccinia virions enter cells by different mechanisms. J. Gen. Virol. 78, 877-887.
50. Vanderplasschen, A., and Smith, G. L. (1997). A novel virus binding assay using confocal microscopy: Demonstration that the intracellular and extracellular vaccinia virions bind to different cellular receptors. J. Virol. 71, 4032-4041.
51. Wolffe, E. J., Isaacs, S. N., and Moss, B. (1993). Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination [published erratum appears in J. Virol. (1993) 67, 5709-5711]. J. Virol. 67, 4732-4741.
52. Wolffe, E. J., Isaacs, S. N., and Moss, B. (1993). Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination [published erratum appears in J. Virol. (1993) 67, 5709-5711]. J. Virol. 67, 4732-4741.
53. Wolffe, E. J., Katz, E., Weisberg, A., and Moss, B. (1997). The A34R glycoprotein gene is required for induction of specialized actin-containing microvilli and efficient cell-to-cell transmission of vaccinia virus. J. Virol. 71, 3904-3915.